Study of the multidrug anti-cancer therapy R-CHOP (Table 1) supports this hypothesis (Palmer et al., 2019) and an expanded study using more antibiotics could be used to test this hypothesis in tuberculosis. The gene discussed is DDIT3; the disease is cancer.